SCHEMBL8086896

SCHEMBL8086896

COC(=O)C1=C[N]c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
SLC6A3 Q01959 5/20 0.39
SLC6A4 P31645 3/20 0.39
LMNA P02545 1/20 0.39
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38
FGFR2 P21802 1/20 0.38
FGFR4 P22455 1/20 0.38
FGFR3 P22607 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CFTR P13569 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TRPA1 O75762 2/20 0.38
SLC6A2 P23975 1/20 0.37
IDO1 P14902 1/20 0.37
PTPN1 P18031 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8078829 0.77 ALDH1A1 (0.36) TSHRLMNAFGFR1FGFR2FGFR4
SCHEMBL3222329 0.76 BCAT2 (0.38) TSHRFGFR1SRCFGFR2FGFR4
SCHEMBL6650153 0.70 NPC1 (0.38) TSHRSLC6A3SLC6A4FGFR1FGFR2
SCHEMBL9363066 0.68 TSHR (0.47) TSHRSLC6A3SLC6A4LMNAFGFR1
SCHEMBL4786063 0.67 MAPT (0.51) TSHRLMNAFGFR1SRCFGFR2
SCHEMBL69464 0.66 SLC6A3 (0.67) TSHRSLC6A3SLC6A4LMNAALDH1A1
SCHEMBL15514574 0.66 CDC25B (0.55) LMNAFGFR1SRCFGFR2FGFR4
SCHEMBL27358025 0.66 FGFR1 (0.46) TSHRLMNAFGFR1SRCFGFR2
SCHEMBL31315022 0.66 CDC25B (0.55) LMNAFGFR1SRCFGFR2FGFR4
Dimethyl Phthalate SCHEMBL27335020 0.65 TSHR (0.71) TSHRSLC6A3SLC6A4LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP disclosed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO disclosed